SAR exploration of the non-imidazole histamine H3 receptor ligand ZEL-H16 reveals potent inverse agonism

被引:0
|
作者
Wagner, Gabor [1 ]
Mocking, Tamara A. M. [1 ]
Ma, Xiaoyuan [1 ]
Slynko, Inna [1 ]
Pereira, Daniel Da Costa [1 ]
Breeuwer, Robin [1 ]
Rood, Niek J. N. [1 ]
van der Horst, Cas [1 ]
Vischer, Henry F. [1 ]
de Graaf, Chris [1 ]
de Esch, Iwan J. P. [1 ]
Wijtmans, Maikel [1 ]
Leurs, Rob [1 ]
机构
[1] Vrije Univ Amsterdam, Fac Sci, Amsterdam Inst Mol & Life Sci AIMMS, Div Med Chem, De Boelelaan 1108, NL-1081 HZ Amsterdam, Netherlands
关键词
agonism; G protein-coupled receptor (GPCR); histamine H3 receptor; inverse agonism; non-imidazole; PHARMACOLOGICAL CHARACTERIZATION; INHIBITION;
D O I
10.1002/ardp.202200451
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Histamine H-3 receptor (H3R) agonists without an imidazole moiety remain very scarce. Of these, ZEL-H16 (1) has been reported previously as a high-affinity non-imidazole H3R (partial) agonist. Our structure-activity relationship analysis using derivatives of 1 identified both basic moieties as key interaction motifs and the distance of these from the central core as a determinant for H3R affinity. However, in spite of the reported H3R (partial) agonism, in our hands, 1 acts as an inverse agonist for G alpha(i) signaling in a CRE-luciferase reporter gene assay and using an H3R conformational sensor. Inverse agonism was also observed for all of the synthesized derivatives of 1. Docking studies and molecular dynamics simulations suggest ionic interactions/hydrogen bonds to H3R residues D114(3.32) and E206(5.46) as essential interaction points.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs
    Zhang, M
    Ballard, ME
    Pan, LP
    Roberts, S
    Faghih, R
    Cowart, M
    Esbenshade, TA
    Fox, GB
    Decker, MW
    Hancock, AA
    Rueter, LE
    BRAIN RESEARCH, 2005, 1045 (1-2) : 142 - 149
  • [42] Anticonvulsant and procognitive properties of the non-imidazole histamine H3 receptor antagonist DL77 in male adult rats
    Sadek, Bassem
    Saad, Ali
    Subramanian, Dhanasekaran
    Shafiullah, Mohamed
    Lazewska, Dorota
    Kiec-Kononowiczc, Katarzyna
    NEUROPHARMACOLOGY, 2016, 106 : 46 - 55
  • [43] In vitro pharmacological properties of two novel non-imidazole H3 receptor (H3R) antagonists
    B. B. Yao
    D. G. Witte
    T. R. Miller
    K. M. Krueger
    T. L. Carr
    C. H. Kang
    R. Faghih
    Y. L. Bennani
    T. A. Esbenshade
    A. A. Hancock
    Inflammation Research, 2003, 52 (Suppl 1) : s45 - s46
  • [44] Effects of Betahistine at Histamine H3 Receptors: Mixed Inverse Agonism/Agonism In Vitro and Partial Inverse Agonism In Vivo
    Gbahou, F.
    Davenas, E.
    Morisset, S.
    Arrang, J. -M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 334 (03): : 945 - 954
  • [45] Preclinical evaluation of non-imidazole histamine H3 receptor antagonists in comparison to atypical antipsychotics for the treatment of cognitive deficits associated with schizophrenia
    Brown, Jordan W.
    Whitehead, Caroline A.
    Basso, Ana M.
    Rueter, Lynne E.
    Zhang, Min
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (04): : 889 - 904
  • [46] QSAR-BASED MODELLING OF ETHER DERIVATIVES OF 3-PIPERIDINOPROPAN-1-OL AS NON-IMIDAZOLE HISTAMINE H3 RECEPTOR ANTAGONISTS
    Srivastava, A. K.
    Nath, A.
    Chaurasia, Sh.
    Pandey, A.
    OXIDATION COMMUNICATIONS, 2010, 33 (01): : 185 - 194
  • [47] Constitutive activity of the histamine H1 receptor reveals inverse agonism of histamine H1 receptor antagonists
    Bakker, RA
    Wieland, K
    Timmerman, H
    Leurs, R
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 387 (01) : R5 - R7
  • [48] A quantum chemical study on a set of non-imidazole H3 antihistamine molecules
    da Costa, Edson Barbosa
    Trsic, Milan
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2010, 28 (07): : 657 - 663
  • [49] Structure-activity relationships of non-imidazole H3 receptor ligands.: Part 1
    Faghih, R
    Dwight, W
    Gentles, R
    Phelan, K
    Esbenshade, TA
    Ireland, L
    Miller, TR
    Kang, CH
    Fox, GB
    Gopalakrishnan, SM
    Hancock, AA
    Bennani, YL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (15) : 2031 - 2034
  • [50] Piperidino-hydrocarbon compounds as novel non-imidazole histamine H3-receptor antagonists
    Meier, G
    Ligneau, X
    Pertz, HH
    Ganellin, CR
    Schwartz, JC
    Schunack, W
    Stark, H
    BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (08) : 2535 - 2542